Rutin

Rutin is a flavonoid glycoside, meaning a flavonoid bound to one or more sugar units. Its structure pairs quercetin, a common plant flavonol, with rutinose, a disaccharide, and it is also known by names such as rutoside and the outdated term vitamin P ^[3]. As a polyphenol it carries several hydroxyl groups that make it an effective antioxidant, though it is poorly absorbed from the gut and is rapidly broken down and excreted, which limits how much reaches the bloodstream in active form ^[2].

The compound is abundant in the plant kingdom and is a routine part of the human diet, taken in through fruits, vegetables, tea, and wine ^[3]. Buckwheat is a particularly rich source, and rutin is also present in citrus peel, apples, asparagus, and many other plants. Its name derives from Ruta graveolens, the herb rue, which likewise contains it.

Rutin and its chemical relatives, collectively called rutosides, have long been marketed as vasoprotective agents intended to strengthen blood vessels, and they carry a classification as capillary-stabilizing drugs. Clinical research has examined them mainly for conditions affecting the veins. Cochrane reviews have found only low-quality evidence for rutosides in post-thrombotic syndrome, concluding they are not clearly better than placebo or compression stockings ^[1], while a broader review of phlebotonics reported that such agents probably reduce leg swelling by a small amount at the cost of slightly more side effects ^[2]. Laboratory studies continue to explore rutin's antioxidant, anti-inflammatory, and other biological actions ^[3].

Rutin is available as an over-the-counter dietary supplement, often in capsule or tablet form, and semisynthetic derivatives such as the hydroxyethylrutosides are used in some countries as venoactive medicines for chronic venous insufficiency ^[4]. Because it is treated largely as a supplement or plant-derived remedy, product composition and regulation vary from place to place.

Generally well tolerated; mild GI upset and occasional headache are the main sides. Because of antiplatelet activity, caution is warranted with anticoagulants or around surgery. It's a widely used, low-risk bioflavonoid overall.

Rutin has almost no human interaction data, and the honest summary is that what exists is preclinical.

The best characterized mechanism is antithrombotic. Rutin inhibits extracellular protein disulfide isomerase, an enzyme platelets and endothelium require for thrombus formation, and that inhibition blocked thrombosis in animal models before the finding was carried into a small clinical program. On mechanism alone, adding rutin to warfarin, a direct oral anticoagulant or an antiplatelet drug is a plausible route to additive bleeding, though no controlled study has measured it in people.

The second signal is pharmacokinetic. In rats, rutin given with oral paclitaxel raised the drug's peak concentration and total exposure substantially, an effect attributed to inhibition of P-glycoprotein and CYP3A4 in the gut wall; rutin also inhibits CYP3A4 in vitro. Whether flavonoid concentrations reachable from a supplement do the same in humans is untested, and rutin's poor oral bioavailability argues against extrapolating freely. Both signals are best read as theoretical rather than documented.

Checking a whole stack? Run it through interactions + stacks.